In Other News

• Blood-Based Immune Aging Map Could Help Spot Disease Risk Earlier

• Global Survey Finds Pediatric Troponin Testing Lacks Consistent Reference Intervals

• Validated Test Predicts Recurrence Risk and Radiation Benefit in Early-Stage Breast Cancer

• Multi-Cancer Screening Blood Test Gains FDA Breakthrough Designation

• European Approval Expands Liquid Biopsy Use in Advanced Breast Cancer Testing

• AI Tool Predicts Long-Term Cardiovascular Risk from Sleep Study ECG

• Multi-Cancer Screening Blood Test Gains FDA Breakthrough Designation

• Blood-Based Immune Signal Could Reveal Lung Cancer Risk Before Tumors Develop

• AI Histopathology Tool Distinguishes Ewing Sarcoma for Diagnosis

• Prototype Point-of-Care Test Aims to Improve Neonatal Sepsis Diagnosis

• Genomic Screening Expands Detection of Treatable Conditions in Newborns

• Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

• Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

• Age-Based Genetic Testing May Miss Most Inherited Cancer Risk Variants

• Single-Tier Lyme Disease Test Shows High Sensitivity in Early Infection

• Study Questions Broad Fasting Requirements Before Routine Blood Tests

• New NGS Suite Expands Clonality and MRD Research in Lymphoid Malignancies

• Tumor-Informed ctDNA Test Shows Utility Across Gastrointestinal and Gynecologic Cancers

• Pooled Sputum Testing Offers Lower-Cost Molecular Diagnosis for Tuberculosis

• Single-Tier Lyme Disease Test Shows High Sensitivity in Early Infection

• New NGS Suite Expands Clonality and MRD Research in Lymphoid Malignancies

• Elevated Lipoprotein(a) Linked to Long-Term Progression of Carotid Atherosclerosis

• Pooled Sputum Testing Offers Lower-Cost Molecular Diagnosis for Tuberculosis